These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 24977441)

  • 1. Osteoporosis and fractures in HIV/hepatitis C virus coinfection: a systematic review and meta-analysis.
    Dong HV; Cortés YI; Shiau S; Yin MT
    AIDS; 2014 Sep; 28(14):2119-31. PubMed ID: 24977441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of hip fracture associated with hepatitis C virus infection and hepatitis C/human immunodeficiency virus coinfection.
    Lo Re V; Volk J; Newcomb CW; Yang YX; Freeman CP; Hennessy S; Kostman JR; Tebas P; Leonard MB; Localio AR
    Hepatology; 2012 Nov; 56(5):1688-98. PubMed ID: 22619086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of HIV-hepatitis C co-infection on bone mineral density and fracture: a meta-analysis.
    O'Neill TJ; Rivera L; Struchkov V; Zaheen A; Thein HH
    PLoS One; 2014; 9(7):e101493. PubMed ID: 25033046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Differential Effects of Human Immunodeficiency Virus and Hepatitis C Virus on Bone Microarchitecture and Fracture Risk.
    Bedimo RJ; Adams-Huet B; Poindexter J; Brown G; Farukhi I; Castanon R; Turner D; Moore T; Tebas P; Maalouf NM
    Clin Infect Dis; 2018 Apr; 66(9):1442-1447. PubMed ID: 29145609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural Bone Deficits in HIV/HCV-Coinfected, HCV-Monoinfected, and HIV-Monoinfected Women.
    Lo Re V; Lynn K; Stumm ER; Long J; Nezamzadeh MS; Baker JF; Hoofnagle AN; Kapalko AJ; Mounzer K; Zemel BS; Tebas P; Kostman JR; Leonard MB
    J Infect Dis; 2015 Sep; 212(6):924-33. PubMed ID: 25754980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus coinfection as a risk factor for osteoporosis and fracture.
    Bedimo R; Maalouf NM; Lo Re V
    Curr Opin HIV AIDS; 2016 May; 11(3):285-93. PubMed ID: 26890206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV and Bone Complications: Understudied Populations and New Management Strategies.
    Yin MT; Brown TT
    Curr HIV/AIDS Rep; 2016 Dec; 13(6):349-358. PubMed ID: 27730445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of low and high-energy fractures in persons with and without HIV infection: a Danish population-based cohort study.
    Hansen AB; Gerstoft J; Kronborg G; Larsen CS; Pedersen C; Pedersen G; Obel N
    AIDS; 2012 Jan; 26(3):285-93. PubMed ID: 22095195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of Complications After THA Increases Among Patients Who Are Coinfected With HIV and Hepatitis C.
    Mahure SA; Bosco JA; Slover JD; Vigdorchik J; Iorio R; Schwarzkopf R
    Clin Orthop Relat Res; 2018 Feb; 476(2):356-369. PubMed ID: 29529669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased risk of hip fracture associated with dually treated HIV/hepatitis B virus coinfection.
    Byrne DD; Newcomb CW; Carbonari DM; Nezamzadeh MS; Leidl KB; Herlim M; Yang YX; Hennessy S; Kostman JR; Leonard MB; Localio AR; Lo Re V
    J Viral Hepat; 2015 Nov; 22(11):936-47. PubMed ID: 25754215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunodeficiency virus-infected and uninfected adults with non-genotype 3 hepatitis C virus have less hepatic steatosis than adults with neither infection.
    Price JC; Ma Y; Scherzer R; Korn N; Tillinghast K; Peters MG; Noworolski SM; Tien PC
    Hepatology; 2017 Mar; 65(3):853-863. PubMed ID: 27981599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone fracture among people living with HIV: A systematic review and meta-regression of prevalence, incidence, and risk factors.
    Pramukti I; Lindayani L; Chen YC; Yeh CY; Tai TW; Fetzer S; Ko NY
    PLoS One; 2020; 15(6):e0233501. PubMed ID: 32497105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C Infection and the Risk of Non-Liver-Related Morbidity and Mortality in HIV-Infected Persons in the Swiss HIV Cohort Study.
    Kovari H; Rauch A; Kouyos R; Rougemont M; Cavassini M; Schmid P; Stöckle M; Bernasconi E; Weber R; Ledergerber B;
    Clin Infect Dis; 2017 Feb; 64(4):490-497. PubMed ID: 28172403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of serum albumin and aspartate transaminase with 5-year all-cause mortality in HIV/hepatitis C virus coinfection and HIV monoinfection.
    Scherzer R; Heymsfield SB; Rimland D; Powderly WG; Tien PC; Bacchetti P; Shlipak MG; Grunfeld C;
    AIDS; 2017 Jan; 31(1):71-79. PubMed ID: 27677166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and risk factors for patient-reported joint pain among patients with HIV/hepatitis C coinfection, hepatitis C monoinfection, and HIV monoinfection.
    Ogdie A; Pang WG; Forde KA; Samir BD; Mulugeta L; Chang KM; Kaplan DE; Amorosa VK; Kostman JR; Reddy RK; Schumacher RH; Lo Re V
    BMC Musculoskelet Disord; 2015 Apr; 16():93. PubMed ID: 25896674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of CD4⁺ T-cell immune activation and interleukin 10 levels among HIV, hepatitis C virus, and HIV/HCV-coinfected patients.
    Hodowanec AC; Brady KE; Gao W; Kincaid SL; Plants J; Bahk M; Landay AL; Huhn GD
    J Acquir Immune Defic Syndr; 2013 Nov; 64(3):232-40. PubMed ID: 24131865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of hepatic FOXP3+ T-lymphocytes in HIV/hepatitis C coinfection.
    Williams SK; Donaldson E; Van der Kleij T; Dixon L; Fisher M; Tibble J; Gilleece Y; Klenerman P; Banham AH; Howard M; Webster DP
    J Viral Hepat; 2014 Apr; 21(4):251-9. PubMed ID: 24597693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV Infection, HCV Coinfection, and Alcohol Use: Associations with Microbial Translocation and Immune Activation.
    Monnig MA; Cohen R; Ramratnam B; McAdams M; Tashima K; Monti PM
    Alcohol Clin Exp Res; 2019 Jun; 43(6):1126-1134. PubMed ID: 30908642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of Liver Fibrosis and Microbial Translocation to Immune Activation in Persons Infected With HIV and/or Hepatitis C Virus.
    Reid M; Ma Y; Scherzer R; Price JC; French AL; Huhn GD; Plankey MW; Peters M; Grunfeld C; Tien PC
    J Infect Dis; 2018 Mar; 217(8):1289-1297. PubMed ID: 29304196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.